NLS Pharmaceutics's total assets for Q2 2024 were $1.19M, a decrease of -35.37% from the previous quarter. NLSP total liabilities were $10.46M for the fiscal quarter, a -2.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.